MedPath
NMPA Approval

Letrozole Tablets

国药准字H20249070

October 16, 2024

Drug Information

来曲唑片

片剂

2.5mg

化学药品

October 16, 2024

Company Information

Applicant Company

北京市通州区广源西街13号院8号楼3层101

Manufacturing Company

吉林省梅河口市湘江路66号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

来曲唑片 - NMPA 批准文号 | MedPath